Edwards EVOQUE Eos MISCEND Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 123 participants.

Also called NCT02718001

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 123 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02718001
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02718001. Allocation not applicable; no masking; primary purpose treatment. Start 2015-02-06 (actual); primary completion 2028-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Edwards EVOQUE Eos MISCEND Study
Condition
Mitral Valve Regurgitation (Degenerative or Functional)
Intervention (Device)
Edwards EVOQUE Eos Mitral Valve Replacement System
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct02718001
Content hash
cf915dd3006048866f74a23685fc4a15c2b0bf8c58dccdefc547bf8d825f76a9